BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 19539780)

  • 1. Reduction of oxidative stress does not attenuate the development of angiotensin II-dependent hypertension in Ren-2 transgenic rats.
    Kopkan L; Husková Z; Vanourková Z; Thumová M; Skaroupková P; Malý J; Kramer HJ; Dvorák P; Cervenka L
    Vascul Pharmacol; 2009; 51(2-3):175-81. PubMed ID: 19539780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of changes in sodium balance on plasma and kidney angiotensin II levels in anesthetized and conscious Ren-2 transgenic rats.
    Husková Z; Kramer HJ; Vanourková Z; Cervenka L
    J Hypertens; 2006 Mar; 24(3):517-27. PubMed ID: 16467655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of nitric oxide and oxidative stress in the regulation of blood pressure and renal function in prehypertensive Ren-2 transgenic rats.
    Vanecková I; Kramer HJ; Novotná J; Kazdová L; Opocenský M; Bader M; Ganten D; Cervenka L
    Kidney Blood Press Res; 2005; 28(2):117-26. PubMed ID: 15795515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superoxide and its interaction with nitric oxide modulates renal function in prehypertensive Ren-2 transgenic rats.
    Kopkan L; Husková Z; Vanourková Z; Thumová M; Skaroupková P; Cervenka L; Majid DS
    J Hypertens; 2007 Nov; 25(11):2257-65. PubMed ID: 17921820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats.
    Chábová VC; Kramer HJ; Vanecková I; Vernerová Z; Eis V; Tesar V; Skaroupková P; Thumová M; Schejbalová S; Husková Z; Vanourková Z; Kolský A; Imig JD; Cervenka L
    Vascul Pharmacol; 2007; 47(2-3):145-59. PubMed ID: 17604232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat.
    Whaley-Connell A; Govindarajan G; Habibi J; Hayden MR; Cooper SA; Wei Y; Ma L; Qazi M; Link D; Karuparthi PR; Stump C; Ferrario C; Sowers JR
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E355-63. PubMed ID: 17440033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dietary salt load and salt depletion on the course of hypertension and angiotensin II levels in male and female heterozygous Ren-2 transgenic rats.
    Husková Z; Kramer H; Vanourková Z; Thumová M; Malý J; Opocenský M; Skaroupková P; Kolský A; Vernerová Z; Cervenka L
    Kidney Blood Press Res; 2007; 30(1):45-55. PubMed ID: 17259738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats.
    Rakusan D; Kujal P; Kramer HJ; Husková Z; Vanourková Z; Vernerová Z; Mrázová I; Thumová M; Cervenka L; Vanecková I
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F758-66. PubMed ID: 20668096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of anesthesia on plasma and kidney ANG II levels in normotensive and ANG II-dependent hypertensive rats.
    Husková Z; Kramer HJ; Thumová M; Vanourková Z; Bürgelová M; Teplan V; Malý J; Cervenka L
    Kidney Blood Press Res; 2006; 29(2):74-83. PubMed ID: 16651849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin reverses target organ damage and oxidative stress in Angiotensin II hypertension: comparison with apocynin, tempol, and hydralazine.
    Rugale C; Delbosc S; Mimran A; Jover B
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):293-8. PubMed ID: 17878758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac and renal antioxidant enzymes and effects of tempol in hyperthyroid rats.
    Moreno JM; Rodríguez Gómez I; Wangensteen R; Osuna A; Bueno P; Vargas F
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E776-83. PubMed ID: 15941780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antioxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat.
    Zhang Y; Croft KD; Mori TA; Schyvens CG; McKenzie KU; Whitworth JA
    Am J Hypertens; 2004 Mar; 17(3):260-5. PubMed ID: 15001201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined suppression of the intrarenal and circulating vasoconstrictor renin-ACE-ANG II axis and augmentation of the vasodilator ACE2-ANG 1-7-Mas axis attenuates the systemic hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
    Červenka L; Bíbová J; Husková Z; Vaňourková Z; Kramer HJ; Herget J; Jíchová Š; Sadowski J; Hampl V
    Physiol Res; 2015; 64(1):11-24. PubMed ID: 25194129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AT1 receptor antisense therapy transiently lowers blood pressure in Ren-2 transgenic rats.
    Vanecková I; Kopkan L; Husková Z; Vanourková Z; Schejbalová S; Cervenka L; Kramer HJ
    Vascul Pharmacol; 2007 Jul; 47(1):63-7. PubMed ID: 17521968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Castration has antihypertensive and organoprotective effects in male but not in female heterozygous Ren-2 rats.
    Vaněčková I; Husková Z; Vaňourková Z; Cervenka L
    Kidney Blood Press Res; 2011; 34(1):46-52. PubMed ID: 21178362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inappropriately high circulating and intrarenal angiotensin II levels during dietary salt loading exacerbate hypertension in Cyp1a1-Ren-2 transgenic rats.
    Husková Z; Vanourková Z; Erbanová M; Thumová M; Opocenský M; Mullins JJ; Kramer HJ; Bürgelová M; Cervenka L
    J Hypertens; 2010 Mar; 28(3):495-509. PubMed ID: 19927008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension system.
    Iglarz M; Touyz RM; Viel EC; Amiri F; Schiffrin EL
    Am J Hypertens; 2004 Jul; 17(7):597-603. PubMed ID: 15243979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II formation in the kidney and nephrosclerosis in Ren-2 hypertensive rats.
    Hartner A; Porst M; Klanke B; Cordasic N; Veelken R; Hilgers KF
    Nephrol Dial Transplant; 2006 Jul; 21(7):1778-85. PubMed ID: 16522658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin receptor blockade does not affect blood pressure or angiotensin II levels in CYP1A1-Ren-2 transgenic rats with acutely induced hypertension.
    Vanourková Z; Kramer HJ; Erbanová M; Bäcker A; Cervenka L; Husková Z; Chábová VC; Tesar V; Dvorák P; Malý J; Vanecková I
    Vascul Pharmacol; 2009; 50(5-6):194-9. PubMed ID: 19563737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats.
    Peiró C; Llergo JL; Angulo J; López-Novoa JM; Rodríguez-López A; Rodríguez-Mañas L; Sánchez-Ferrer CF
    Br J Pharmacol; 1997 Aug; 121(7):1438-44. PubMed ID: 9257925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.